U.S. FDA

U.S. FDA

04/20/2026 03:37:31 PM

Just published: FDA moves from vision to real progress. @JAMA_current https://jamanetwork.com/journals/jama/fullarticle/2848148?resultClick=1…

U.S. FDA

04/20/2026 12:13:35 PM

In year 1 of its Roadmap to Reducing Animal Testing, the FDA has successfully launched several key initiatives and advanced human-relevant alternatives. Replacing outdated methods with cutting-edge approaches that better predict safety and efficacy is the future of science:

U.S. FDA

04/16/2026 05:30:39 PM

The FDA is moving forward on men's health by encouraging sponsors of approved testosterone replacement therapy products to explore a potential new use—treating low libido in men with idiopathic hypogonadism. https://fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men…Emerging data suggest this may help men

U.S. FDA

04/16/2026 10:46:34 AM

RT @HHSResponse: In @DrMakaryFDA's first year, the @US_FDA had record numbers of approvals. 67 new medications 39 new devices 91 new…

U.S. FDA

04/16/2026 08:11:33 AM

Reminder – registration is closing on April 24 for those who want to speak at the FDA’s June 4 public hearing on the Commissioner’s National Priority Voucher (CNPV) program—a fast review pathway for drugs of national importance. For more information: https://fda.gov/news-events/fda-meetings-conferences-and-workshops/registration-commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing…

U.S. FDA

04/15/2026 09:39:34 AM

Curious about menopausal hormone therapy (MHT)? Join @FDAWomen and @FDA_Drug_Info on 4/23 for to explore: The history of MHT regulation Recent labeling updates to MHT What these changes mean for More: https://fda.gov/science-research/fda-grand-rounds/fda-grand-rounds-presented-office-womens-health-fda-menopausal-hormone-therapy-mht-labeling…

U.S. FDA

04/14/2026 11:59:32 AM

Negative trial results often go unreported by companies and researchers, leaving significant gaps in the public record. Reporting results is not optional—it’s a legal and ethical obligation that helps protect patients and strengthen scientific integrity. https://fda.gov/news-events/press-announcements/fda-reminds-more-2200-sponsors-and-researchers-disclose-trial-results…

U.S. FDA

04/13/2026 12:34:34 PM

The FDA has reminded over 2,200 medical product companies and researchers of their legal requirement to submit clinical trial results to http://ClinicalTrials.gov Currently, 29.6% of required trial results are missing from the database. Transparency in research is essential to

U.S. FDA

04/13/2026 10:50:34 AM

In 2025 we tested 102 samples of honey for hidden sweeteners. Most honey passed the test—but even a small amount of fraud matters. We’re staying vigilant to protect the integrity of your food. https://fda.gov/food/hfp-constituent-updates/fda-releases-fy25-sampling-results-economically-motivated-adulteration-honey…

U.S. FDA

04/10/2026 05:47:34 PM

FDA issued a warning letter to a Texas medical spa for failing to follow federal requirements designed to ensure prescription drugs are safe, traceable, and come from verified sources. These safeguards help protect patients from counterfeit or unsafe products. Learn more:

1